Pharmaceutical company Celgene agreed yesterday to invest $25m in NantHealth, a US-based developer of a cloud computing platform for healthcare.
Celgene previously invested $75m in NantHealth’s sister company, NantBioScience, earlier this year, and its commitment to NantHealth is part of a collaboration that will involve Celgene accessing NantHealth’s knowledge base and clinical operating system to aid clinicians and medical researchers in developing cancer drugs.
NantHealth, part of the NantWorks group of companies, secured $100m in funding from sovereign wealth fund the Kuwait Investment Authority in April, having raised an undisclosed sum from mobile device maker Blackberry earlier the same month.
“These investments not only accelerate NantHealth in its pursuit of transforming healthcare, but also prove NantWorks as a meaningful innovation accelerator for our partners and their industry verticals.” said CEO Patrick Soon-Shiong.
Verizon Ventures, the corporate venturing arm of telecommunications company Verizon, also invested an undisclosed amount in NantHealth in 2012.